Quantitative discrimination of Aggregatibacter actinomycetemcomitans highly leukotoxic JP2 clone from non-JP2 clones in diagnosis of aggressive periodontitis

BMC Infectious Diseases

Toshihiro Ansai⁶  Shuji Awano⁶  Tatsuji Nishihara²  Hideaki Hayashida⁵  Tomonori Hoshino¹  Hideo Miyazaki³  Oum-Keltoum Ennibi⁴  Akihiro Yoshida⁶ 

[1]Department of Pediatric Dentistry, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

[2]Division of Infections and Molecular Biology, Kyushu Dental College, Kitakyushu, Japan

[3]Department of Oral Health Science, Niigata University Graduate School of Medical and Dental Science, Niigata, Japan

[4]Département de Parodontologie, Faculté de Médecine Dentaire, Université Mohammed V Souissi, Rabat, Morocco

[5]Department of Preventive Dentistry, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

[6]Division of Community Oral Health Science, Kyushu Dental College, Kitakyushu, Japan

关键词: Quantification;    qPCR;    Non-JP2;    JP2;    Aggressive periodontitis;    Aggregatibacter actinomycetemcomitans;   

Others  :  1159638
DOI  :  10.1186/1471-2334-12-253

 received in 2012-07-17, accepted in 2012-10-09,  发布年份 2012

【 摘 要 】

Background

Aggregatibacter actinomycetemcomitans is the etiological agent of periodontitis, and there is a strong association between clone JP2 and aggressive periodontitis in adolescents of African descent. The JP2 clone has an approximately 530-bp deletion (∆530) in the promoter region of the lkt/ltx gene, which encodes leukotoxin, and this clone has high leukotoxic activity. Therefore, this clone is very important in aggressive periodontitis. To diagnose this disease, culture methods and conventional PCR techniques are used. However, quantitative detection based on qPCR for the JP2 clone has not been developed due to genetic difficulties. In this study, we developed a qPCR-based quantification method specific to the JP2 clone.

Methods

Based on our analysis of the DNA sequence of the lkt/ltx gene and its flanking region, we designed a reverse primer specific for the ∆530 deletion border sequence and developed a JP2-specific PCR-based quantification method using this primer. We also analyzed the DNA sequence of the ∆530 locus and found it to be highly conserved (97–100%) among 17 non-JP2 strains. Using the ∆530 locus, we designed a qPCR primer–probe set specific to non-JP2 clones. Next, we determined the numbers of JP2 and non-JP2 clone cells in the periodontal pockets of patients with aggressive periodontitis.

Results

The JP2-specific primers specifically amplified the genomic DNA of the A. actinomycetemcomitans JP2 clone and did not react with other bacterial DNA, whereas the non-JP2 specific primers reacted only with A. actinomycetemcomitans non-JP2 clones. Samples from the 88 periodontal sites in the 11 patients with aggressive periodontitis were analyzed. The bacterial cell numbers in 88 periodontal sites ranged from 0 to 4.8 × 10⁸ (mean 1.28 × 10⁷) for JP2 clones and from 0 to 1.6 × 10⁶ for non-JP2 clones (mean 1.84 × 10⁵). There were significant differences in the JP2 cell number between a clinical attachment level (CAL) ≤6 mm and a level ≥7 mm (p < 0.01). Our new qPCR-based JP2- and non-JP2-specific quantitative detection assay is applicable to the diagnosis of aggressive periodontitis with A. actinomycetemcomitans.

Conclusions

We successfully developed a quantitative and discriminative PCR-based method for the detection of A. actinomycetemcomitans JP2 and non-JP2 clones. This technique will contribute to future analyses of the quantitative relationship between this organism and aggressive periodontitis.

【 授权许可】

   
2012 Yoshida et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]van Dyke TE, Serhan CN: Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases. J Dent Res 2003, 82:82-90.
• [2]Friedewald VE, Kornman KS, Beck JD, Genco R, Goldfine A, Libby P, Offenbacher S, Ridker PM, Van Dyke TE, Roberts WC: American Journal of Cardiology; Journal of Periodontology: The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: periodontitis and atherosclerotic cardiovascular disease. Am J Cardiol 2009, 104:59-68.
• [3]Ishihara K, Nabuchi A, Ito R, Miyachi K, Kuramitsu HK, Okuda K: Correlation between detection rates of periodontopathic bacterial DNA in coronary stenotic artery plaque and in dental plaque samples. J Clin Microbiol 2004, 42:1313–1315. Erratum in: J Clin Microbiol 2004, 42:5437.
• [4]Offenbacher S, Boggess KA, Murtha AP, Jared HL, Lieff S, McKaig RG, Mauriello SM, Moss KL, Beck JD: Progressive periodontal disease and risk of very preterm delivery. Obstet Gynecol 2006, 107:29-36.
• [5]American Academy of Periodontology: Parameter on aggressive periodontitis. J Periodontol 2000, 71:867-869.
• [6]Pihlstrom BL, Fine DH: Aggressive periodontitis in adolescents in Morocco. Lancet 2008, 371:188-189.
• [7]Rylev M, Bek-Thomsen M, Reinholdt J, Ennibi OK, Kilian M: Microbiological and immunological characteristics of young Moroccan patients with aggressive periodontitis with and without detectable Aggregatibacter actinomycetemcomitans JP2 infection. Mol Oral Microbiol 2011, 26:35-51.
• [8]Haubek D, Ennibi OK, Poulsen K, Vaeth M, Poulsen S, Kilian M: Risk of aggressive periodontitis in adolescent carriers of the JP2 clone of Aggregatibacter (Actinobacillus) actinomycetemcomitans in Morocco: a prospective longitudinal cohort study. Lancet 2008, 371:237-242.
• [9]Nørskov-Lauritsen N, Nørskov-Lauritsen M: Reclassification of Actinobacillus actinomycetemcomitans, Haemophilus aphrophilus, Haemophilus paraphrophilus and Haemophilus segnisasAggregatibacter actinomycetemcomitans gen. nov., comb. nov.,Aggregatibacter aphrophiluscomb. nov. and Aggregatibacter segniscomb. nov., and emended description of Aggregatibacter aphrophilus to include V factor-dependent and V factor-independent isolates. Int J Syst Evol Microbiol 2006, 56:2135-2146.
• [10]Zambon JJ: Actinobacillus actinomycetemcomitans in human periodontal disease. J Clin Periodontol 1985, 12:1-20.
• [11]Haubek DM, Dirienzo J, Tinoco EM, Westergaard J, Lopez NJ, Chung CP, Poulsen K, Kilian M: Racial tropism of a highly toxic clone of Actinobacillus actinomycetemcomitans associated with juvenile periodontitis. J Clin Microbiol 1997, 35:3037-3042.
• [12]Haubek D, Poulsen K, Asikainen S, Kilian M: Evidence for absence in northern Europe of especially virulent clonal types of Actinobacillus actinomycetemcomitans. J Clin Microbiol 1995, 33:395-401.
• [13]Haubek D, Poulsen K, Kilian M: Microevolution and patterns of dissemination of the JP2 clone of Aggregatibacter (Actinobacillus) actinomycetemcomitans. Infect Immun 2007, 75:3080-3088.
• [14]Haubek D, Poulsen K, Westergaard J, Dahlèn G, Kilian M: Highly toxic clone of Actinobacillus actinomycetemcomitans in geographically widespread cases of juvenile periodontitis in adolescents of African origin. J Clin Microbiol 1996, 34:1576-1578.
• [15]Rylev M, Kilian M: Prevalence and distribution of principal periodontal pathogens worldwide. J Clin Periodontol 2008, 35:346-361.
• [16]Cortelli SC, Costa FO, Kawai T, Aquino DR, Franco GC, Ohara K, Roman-Torres CV, Cortelli JR: Diminished treatment response of periodontally diseased patients infected with the JP2 clone of Aggregatibacter (Actinobacillus) actinomycetemcomitans. J Clin Microbiol 2009, 47:2018-2025.
• [17]Brogan JM, Lally ET, Poulsen K, Kilian M, Demuth DR: Regulation of Actinobacillus actinomycetemcomitans leukotoxin expression: analysis of the promoter regions of leukotoxic and minimally leukotoxic strains. Infect Immun 1994, 62:501-508.
• [18]Contreras A, Rusitanonta T, Chen C, Wagner WG, Michalowicz BS, Slots J: Frequency of 530-bp deletion in Actinobacillus actinomycetemcomitans leukotoxin promoter region. Oral Microbiol Immunol 2000, 15:338-340.
• [19]He T, Nishihara T, Demuth DR, Ishikawa I: A novel insertion sequence increases the expression of leukotoxicity in Actinobacillus actinomycetemcomitans clinical isolates. J Periodontol 1999, 70:1261-1268.
• [20]Kolodrubetz D, Spitznagel J Jr, Wang B, Phillips LH, Jacobs C, Kraig E: cis Elements and trans factors are both important in strain-specific regulation of the leukotoxin gene in Actinobacillus actinomycetemcomitans. Infect Immun 1996, 64:3451-3460.
• [21]Haubek D, Ennibi OK, Abdellaoui L, Benzarti N, Poulsen S: Attachment loss in Moroccan early onset periodontitis patients and infection with the JP2-type of Actinobacillus actinomycetemcomitans. J Clin Periodontol 2002, 29:657-660.
• [22]Haubek D, Ennibi OK, Poulsen K, Benzarti N, Baelum V: The highly leukotoxic JP2 clone of Actinobacillus actinomycetemcomitans and progression of periodontal attachment loss. J Dent Res 2004, 83:767-770.
• [23]Haubek D, Ennibi OK, Poulsen K, Poulsen S, Benzarti N, Kilian M: Early-onset periodontitis in Morocco is associated with the highly leukotoxic clone of Actinobacillus actinomycetemcomitans. J Dent Res 2001, 80:1580-1583.
• [24]Poulsen K, Ennibi OK, Haubek D: Improved PCR for detection of the highly leukotoxic JP2 clone of Actinobacillus actinomycetemcomitans in subgingival plaque samples. J Clin Microbiol 2003, 41:4829-4832.
• [25]Seki M, Poulsen K, Haubek D, Kilian M: Novel loop-mediated isothermal amplification method for detection of the JP2 clone of Aggregatibacter actinomycetemcomitans in subgingival plaque. J Clin Microbiol 2008, 46:1113-1115.
• [26]Orrù G, Marini MF, Ciusa ML, Isola D, Cotti M, Baldoni M, Piras V, Pisano E, Montaldo C: Usefulness of real time PCR for the differentiation and quantification of 652 and JP2 Actinobacillus actinomycetemcomitans genotypes in dental plaque and saliva. BMC Infect Dis 2006, 6:98. BioMed Central Full Text
• [27]Kawada M, Yoshida A, Suzuki N, Nakano Y, Saito T, Oho T, Koga T: Prevalence of Porphyromonas gingivalis in relation to periodontal status assessed by real-time PCR. Oral Microbiol Immunol 2004, 19:289-292.
• [28]Simonson LG, Goodman CH, Bial JJ, Morton HE: Quantitative relationship of Treponema denticola to severity of periodontal disease. Infect Immun 1988, 56:726-728.
• [29]Yoshida A, Kawada M, Suzuki N, Nakano Y, Oho T, Saito T, Yamashita Y: TaqMan real-time polymerase chain reaction assay for the correlation of Treponema denticola numbers with the severity of periodontal disease. Oral Microbiol Immunol 2004, 19:196-200.
• [30]Haubek D, Ennibi OK, Vaeth M, Poulsen S, Poulsen K: Stability of the JP2 clone of Aggregatibacter actinomycetemcomitans. J Dent Res 2009, 88:856-860.
• [31]Yoshida A, Suzuki N, Nakano Y, Oho T, Kawada M, Koga T: Development of a 5' fluorogenic nuclease-based real-time PCR assay for quantitative detection of Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. J Clin Microbiol 2003, 41:863-866.
• [32]Leys EJ, Griffen AL, Strong SJ, Fuerst PA: Detection and strain identification of Actinobacillus actinomycetemcomitans by nested PCR. J Clin Microbiol 1994, 32:1288-1294.
• [33]Osawa R, Yoshida A, Masakiyo Y, Nagashima S, Ansai T, Watari H, Notomi T, Takehara T: Rapid detection of Actinobacillus actinomycetemcomitans using a loop-mediated isothermal amplification method. Oral Microbiol Immunol 2007, 22:252-259.
• [34]Sreenivasan PK, LeBlanc DJ, Lee LN, Fives-Taylor P: Transformation of Actinobacillus actinomycetemcomitans by electroporation, utilizing constructed shuttle plasmids. Infect Immun 1991, 59:4621-4627.
• [35]Sambrook J, Fritsch EF, Maniatis T: Molecular cloning: a laboratory manual. 2nd edition. N.Y.: Cold Spring Harbor Laboratory Press, Cold Spring Harbor,; 1989.